These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38401583)

  • 1. Deficiency of polypeptide N-acetylgalactosamine transferase 9 contributes to a risk for Parkinson's disease via mitochondrial dysfunctions.
    Peng Y; Wang C; Ma W; Chen Q; Xu G; Kong Y; Ma L; Ding W; Zhang W
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130347. PubMed ID: 38401583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ADP/ATP Translocase 1 as a Novel Glycoprotein and Its Association with Parkinson's Disease.
    Zhang W; Liu J; Chen Q; Ding W; Li S; Ma L
    Neurochem Res; 2022 Nov; 47(11):3355-3368. PubMed ID: 35962937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane.
    Lackman JJ; Goth CK; Halim A; Vakhrushev SY; Clausen H; Petäjä-Repo UE
    Cell Signal; 2018 Jan; 42():184-193. PubMed ID: 29097258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GALNT9 gene expression is a prognostic marker in neuroblastoma patients.
    Berois N; Gattolliat CH; Barrios E; Capandeguy L; Douc-Rasy S; Valteau-Couanet D; Bénard J; Osinaga E
    Clin Chem; 2013 Jan; 59(1):225-33. PubMed ID: 23136245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
    Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
    Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of microtubule-associated protein 6 glycosylated with Gal-(β-1,3)-GalNAc in Parkinson's disease.
    Ma L; Song J; Sun X; Ding W; Fan K; Qi M; Xu Y; Zhang W
    Aging (Albany NY); 2019 Jul; 11(13):4597-4610. PubMed ID: 31289257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
    Wandall HH; Irazoqui F; Tarp MA; Bennett EP; Mandel U; Takeuchi H; Kato K; Irimura T; Suryanarayanan G; Hollingsworth MA; Clausen H
    Glycobiology; 2007 Apr; 17(4):374-87. PubMed ID: 17215257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells.
    Schjoldager KT; Vakhrushev SY; Kong Y; Steentoft C; Nudelman AS; Pedersen NB; Wandall HH; Mandel U; Bennett EP; Levery SB; Clausen H
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9893-8. PubMed ID: 22566642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.
    Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D
    J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
    Seo MH; Yeo S
    Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic epigenetic regulation of initial O-glycosylation by UDP-N-Acetylgalactosamine:Peptide N-acetylgalactosaminyltransferases. site-specific glycosylation of MUC1 repeat peptide influences the substrate qualities at adjacent or distant Ser/Thr positions.
    Hanisch FG; Müller S; Hassan H; Clausen H; Zachara N; Gooley AA; Paulsen H; Alving K; Peter-Katalinic J
    J Biol Chem; 1999 Apr; 274(15):9946-54. PubMed ID: 10187769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
    Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of
    Cejas RB; Lorenz V; Garay YC; Irazoqui FJ
    J Biol Chem; 2019 Mar; 294(9):2997-3011. PubMed ID: 30591584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyl-transferase from the snail Biomphalaria glabrata - substrate specificity and preference of glycosylation sites.
    Taus C; Windwarder M; Altmann F; Grabherr R; Staudacher E
    Glycoconj J; 2014 Dec; 31(9):661-70. PubMed ID: 25338825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection of Andrographolide against Neurotoxin MPP
    Prasertsuksri P; Kraokaew P; Pranweerapaiboon K; Sobhon P; Chaithirayanon K
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of TRPV1 and TRPA1 Channels Function by Sea Anemones' Peptides Enhances the Viability of SH-SY5Y Cell Model of Parkinson's Disease.
    Kolesova YS; Stroylova YY; Maleeva EE; Moysenovich AM; Pozdyshev DV; Muronetz VI; Andreev YA
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
    Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
    BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy.
    Yang Z; Halim A; Narimatsu Y; Jitendra Joshi H; Steentoft C; Schjoldager KT; Alder Schulz M; Sealover NR; Kayser KJ; Paul Bennett E; Levery SB; Vakhrushev SY; Clausen H
    Mol Cell Proteomics; 2014 Dec; 13(12):3224-35. PubMed ID: 25092905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
    Park JS; Choe K; Lee HJ; Park TJ; Kim MO
    J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
    Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.